Q2
LONG ANSWER
10M
★ High-yield
Describe the aetiology, classification, morphology and spread of gastric carcinoma.
Introduction
Gastric carcinoma is a malignant epithelial tumour of the stomach, accounting for over 90% of gastric malignancies.
- Incidence varies greatly by region — very high in Japan, Korea, China and parts of South America; in India it is commonest in the south and north-east
- Male to female ratio about 2:1; usually over 50 years
- Site — 50–60% in the pylorus and antrum, and more on the lesser curvature than the greater
Aetiology
| Factor | Detail |
|---|---|
| Helicobacter pylori | A WHO class I carcinogen; causes chronic gastritis → atrophy → intestinal metaplasia → dysplasia → carcinoma. Also causes gastric malt lymphoma |
| Diet | Nitrosamines; smoked, salted and pickled foods; low intake of fresh fruit and vegetables (vitamins C and E are protective) |
| Precursor conditions | Chronic atrophic gastritis, intestinal metaplasia, dysplasia, pernicious anaemia (autoimmune gastritis), gastric adenomatous polyps, menetrier disease, previous partial gastrectomy (after 15–20 years) |
| Genetic | Blood group A; family history; germline E-cadherin (CDH1) mutation causes hereditary diffuse gastric cancer; HNPCC; familial adenomatous polyposis |
| Other | Smoking; low socioeconomic status; Epstein–Barr virus in about 10% |
Classification
Early and advanced gastric carcinoma
| Type | Definition | Prognosis |
|---|---|---|
| Early gastric carcinoma | Confined to the mucosa and submucosa, regardless of lymph node involvement | 5-year survival above 90% |
| Advanced gastric carcinoma | Extends beyond the submucosa into the muscularis propria or further | 5-year survival under 20% |
- The definition of "early" depends on depth, not on nodes or size — a common examination trap
- Japan detects a high proportion at the early stage through population endoscopic screening, which is why its survival figures are so much better
Macroscopic (Borrmann) types of advanced carcinoma
- I — polypoid or fungating
- II — ulcerated with sharply raised, heaped margins
- III — ulcerated with diffuse infiltration of the margins
- IV — diffusely infiltrative; when the whole stomach is involved it becomes a rigid, thickened, contracted organ — "linitis plastica" or the leather-bottle stomach
Lauren Histological Classification
| Feature | Intestinal type | Diffuse type |
|---|---|---|
| Differentiation | Well differentiated; forms glands resembling intestinal epithelium | Poorly differentiated; NO gland formation |
| Cells | Columnar, cohesive | Signet ring cells — a mucin vacuole displacing the nucleus to the periphery; discohesive and infiltrate singly |
| Age | Older, over 50 | Younger patients |
| Sex | Male predominance | Equal |
| Precursor lesion | Chronic atrophic gastritis with intestinal metaplasia | None identified |
| Genetics | APC, p53, microsatellite instability | E-cadherin (CDH1) loss — explaining the loss of cell cohesion |
| Macroscopic form | Polypoid or ulcerated mass | Linitis plastica |
| Spread | Haematogenous, to liver | Transcoelomic; krukenberg tumour |
| Environmental link | Strong — declining in incidence | Weak — incidence stable |
| Prognosis | Better | Worse |
CLINICAL PEARL
Loss of E-cadherin explains the entire diffuse phenotype. E-cadherin is the molecule that holds epithelial cells to one another. Lose it and the cells cannot form glands, infiltrate singly rather than as a mass, and spread diffusely through the wall — producing linitis plastica and the signet-ring morphology. One molecular defect accounts for the histology, the naked-eye appearance and the poor prognosis together.
Spread and Clinical Features
| Route | Sites |
|---|---|
| Direct | Pancreas, transverse colon, liver, omentum, spleen |
| Lymphatic | Perigastric nodes; then the left supraclavicular node — virchow node (troisier sign) |
| Haematogenous | Liver (commonest), lung, bone, brain |
| Transcoelomic | Peritoneal seeding; bilateral ovarian deposits = krukenberg tumour (signet-ring cells in a fibrous stroma); "sister MARY JOSEPH nodule" at the umbilicus; BLUMER shelf in the rectovesical pouch |
- Early disease is asymptomatic or gives vague dyspepsia, which is why most present late
- Later — weight loss, epigastric pain, anorexia (especially for meat), vomiting, iron deficiency anaemia, a palpable epigastric mass
- Paraneoplastic — acanthosis nigricans, the sign of Leser–Trelat, migratory thrombophlebitis, dermatomyositis, microangiopathic haemolytic anaemia
Applied Aspects
- Endoscopy with multiple biopsies is the investigation of choice; a single biopsy from an ulcer edge may miss the tumour, and at least 6 to 8 should be taken
- Linitis plastica may yield negative mucosal biopsies, because the tumour infiltrates the submucosa and muscularis while sparing the surface — deep or endoscopic ultrasound-guided biopsy may be needed
- H. Pylori eradication reduces the risk, and is the main preventable factor; refrigeration and fresh food have driven the worldwide decline in incidence
- Staging by CT and laparoscopy; peritoneal disease found at laparoscopy spares the patient a futile laparotomy
- Surgery is the only curative treatment, with perioperative chemotherapy; HER2 testing guides trastuzumab in advanced disease
- Gastric lymphoma (malt) must be separated from carcinoma — it may regress completely with H. Pylori eradication alone, and so has a far better outlook
- Gastrointestinal stromal tumour (GIST) is the other important gastric neoplasm — arising from the interstitial cells of Cajal, CD117 (kit) positive, and treated with imatinib
- Prognosis depends on depth of invasion and nodal status, which is why detecting disease while it is still "early" matters so much more than any treatment advance
- Population endoscopic screening is justified only where incidence is high, as in Japan and Korea; it is not cost-effective in low-incidence populations
All questions in Gastrointestinal & Hepatobiliary Pathology
- Q1Define peptic ulcer. Describe its aetiology, pathogenesis, morphology and complications. Differentiate benign from malignant gastric ulcer. ★
- Q2Describe the aetiology, classification, morphology and spread of gastric carcinoma. ★
- Q3Describe the viruses causing hepatitis. Explain the morphology of acute and chronic hepatitis and the interpretation of hepatitis B serology. ★
- Q4Define cirrhosis. Describe its causes, pathogenesis and morphological types. Add a note on portal hypertension. ★
- Q5Describe inflammatory bowel disease. Differentiate Crohn disease from ulcerative colitis. ★
- SN1Describe Barrett oesophagus and carcinoma of the oesophagus. ★
- SN2Classify colorectal polyps. Describe the adenoma-carcinoma sequence and the morphology of colorectal carcinoma. ★
- SN3Define jaundice. Classify it and describe how the types are distinguished. ★
- SN4Classify gallstones. Describe their pathogenesis, complications and the pathology of cholecystitis. ★
- SN5Differentiate amoebic from pyogenic liver abscess. ★
- SN6Classify malabsorption syndromes. Differentiate coeliac disease from tropical sprue. ★
- SN7Describe hepatocellular carcinoma with its aetiology, morphology and diagnosis.